See beyond retinal structure
Discover Zilia Ocular®, the world’s first commercially available ocular oximeter, and gain a new perspective on retinal health beyond structure alone.
Traditional retinal imaging provides essential information about visible anatomy. However, structural images alone do not directly measure retinal metabolism. Zilia Ocular addresses this gap by combining high-resolution fundus imaging with non-invasive measurement of retinal tissue oxygen saturation (StO₂), a functional biomarker of retinal metabolism.
The platform provides eye care professionals with complementary structural and metabolic information from targeted regions of the retina. This additional functional context can support a broader understanding of retinal physiology during applicable clinical assessment, longitudinal monitoring and research.
Structural imaging meets functional insight
Zilia Ocular combines fundus imaging and spectroscopy in one platform. Using low-intensity light, it captures retinal images and spectral information that are processed to generate quantitative oxygenation measurements.
This dual output allows clinicians to review:
- Retinal structure through high-resolution fundus imaging
- Retinal metabolism through tissue oxygen saturation measurements
Rather than replacing existing retinal imaging technologies, Zilia Ocular adds another layer of objective information to complement structural findings.
Non-invasive, continuous measurement
Zilia Ocular measures retinal tissue oxygen saturation non-invasively in targeted areas of the retina. Its continuous measurement capability can be used to observe real-time metabolic responses to applicable stimuli.
Automated focusing and smooth positioning help facilitate data collection while supporting a comfortable patient experience.
Streamlined data analysis
Zilia Ocular is supported by an intuitive software environment that guides users through acquisition and analysis.
Results are available through Zilia Zone™, a secure cloud-based environment that enables authorized users to:
- Access and review data in real time
- Compare measurements
- Generate reports
- Apply customized tags
- Consult, extract and manage information
Key features
- World’s first commercially available ocular oximeter
- Canadian-developed retinal imaging technology
- Quantitative retinal tissue oxygen saturation (StO₂) measurements
- High-resolution fundus imaging
- Combined structural and metabolic retinal information
- Non-invasive data acquisition using low-intensity light
- Continuous assessment of metabolic responses
- Automated focusing and positioning
- Intuitive acquisition and analysis software
- Secure cloud-based access through Zilia Zone™
- Reporting, comparison and data-management capabilities
Canadian innovation, available through INNOVA
INNOVA is proud to bring Zilia Ocular to eye care professionals across Canada as its exclusive Canadian distributor.
Developed by Zilia, a medical technology company headquartered in Québec City, Zilia Ocular introduces a new metabolic dimension to retinal assessment through quantitative ocular oximetry.
Contact INNOVA to learn more about Zilia Ocular or schedule a demonstration.
For qualified medical professional use only. Refer to the User Manual for Canadian authorized indication for use, cautions and precautions.